gpt-dict.com

舊版 AI 分級 · 資料日期 2026-06-09。尚未採用新版自動摘要；未經專家評讀，涵蓋範圍以本頁來源為限。了解新版流程

輔酶 Q10 (輔酵素 Q10) Coenzyme Q10 × 纖維肌痛症

結論：證據支持

現有 RCT 證據幾乎全為單一西班牙 Cordoba 研究團隊產出的小型試驗 (多為 n=20、300 mg/day、40 天)，雖一致顯示疼痛、疲勞、晨僵改善，但 2022 年 PMC9598746 批判性回顧明確指出『缺乏建立 CoQ10 為纖維肌痛症金標準的科學基礎，需數百人規模 RCT 確證』。

C 🟠 C 薄弱證據 已發布 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 🇹🇼 台灣在地警示 💊 檢驗 / 藥物交互作用

現有 RCT 證據幾乎全為單一西班牙 Cordoba 研究團隊產出的小型試驗 (多為 n=20、300 mg/day、40 天)，雖一致顯示疼痛、疲勞、晨僵改善，但 2022 年 PMC9598746 批判性回顧明確指出『缺乏建立 CoQ10 為纖維肌痛症金標準的科學基礎，需數百人規模 RCT 確證』。

2022 年疲勞統合分析 (PMID 36091835) 雖納入 4 篇 FM 研究並顯示 Hedges' g = -0.398 顯著降低疲勞，但混合多種疾病族群且未針對 FM 子組做敏感性分析。

所有患者導向權威 (Mayo、Cleveland、Harvard、ACR、NFA、NCCIH) 均未將 CoQ10 列為 FM 推薦或建議用途，屬於明顯的『早期正向訊號 + 權威全面沉默』格局，符合 C 級 (證據薄弱、樣本不足、缺乏確證性大型 RCT)。

⚖️

評分透明度

所有分數由 7 層證據引擎計算，過程公開可查
原始分數 0.48
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 已發布
信心度
78%
證據方向大致一致
證據層級
E3
單篇高品質統合分析

各層「支持此療效」的程度

分數越低＝該層越不支持
L2 PubMed原始文獻
0.45
L3 機轉生理合理性
0.45
L1 Examine國際基準
0.50
L11 AI 複核獨立判讀
0.50
L5 臨床機構權威立場
0.55
不支持 中性 / 混合 支持
▸查看完整決策路徑（audit trail）
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.485
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標，未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Effects of Coenzyme Q10, Tryptophan, and Magnesium Supplementation on Fatigue in Patients with Fibromyalgia - A Randomized Trial
PMID: 40151031 2025 RCT (CoQ10+tryptophan+magnesium combination) n = 110
結論：On the PRIMARY fatigue endpoint the trial was effectively null: fatigue improved significantly in the PLACEBO arm while the CoQ10+tryptophan+magnesium arm showed only a non-significant reduction; secondary outcomes (pain intensity, sleep quality, ICAF total) did improve significantly with the supplement.
效應量：Primary fatigue outcome: statistically significant improvement in placebo arm, non-significant change in supplement arm (no between-group benefit; exact effect size not reported in abstract)
前往 PubMed
Coenzyme Q10 supplementation alleviates pain in pregabalin-treated fibromyalgia patients via reducing brain activity and mitochondrial dysfunction
PMID: 31387429 2019 RCT (double-blind) n = 11
結論：As add-on to pregabalin, CoQ10 reduced pain, anxiety and brain activity and lowered mitochondrial oxidative stress/inflammation versus pregabalin-plus-placebo, but the trial was very small (n=11) and reported no effect-size statistics in the abstract.
🟠 品質有限
前往 PubMed
Can coenzyme Q10 improve clinical and molecular parameters in fibromyalgia?
PMID: 23458405 2013 RCT (double-blind) n = 20
結論：CoQ10 300 mg/day for 40 days significantly reduced FIQ score and pain (both p<0.001) and improved fatigue, morning tiredness, visual pain scale and tender points (p<0.01), but only p-values (no effect sizes) were reported in a small single-center sample.
🟠 品質有限 效應量：FIQ p<0.001; pain p<0.001; fatigue/morning tiredness/tender points p<0.01 (magnitudes not reported)
前往 PubMed
NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10
PMID: 23886272 2014 RCT (double-blind) n = 20
結論：Placebo-controlled CoQ10 reduced NLRP3 inflammasome activation and serum IL-1β and IL-18 levels, but the primary endpoints are surrogate inflammatory biomarkers rather than clinical pain/function, and the sample (same Seville group, ~20 patients) is small with no effect sizes reported.
🟠 品質有限
前往 PubMed
Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation
PMID: 23394493 2013 RCT (open-label) n = 16
結論：In juvenile fibromyalgia, ubiquinol-10 supplementation raised CoQ10 status and ameliorated hypercholesterolemia and fatigue, but the endpoints are largely biochemical surrogates, the population is pediatric, and the design lacks a placebo control with a very small sample.
🟠 品質有限
前往 PubMed
Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
PMID: 36091835 2022 系統性回顧 n = 1,126
結論：Across 13 RCTs (1,126 participants) CoQ10 produced a small-to-moderate significant reduction in fatigue (Hedges' g = -0.398, 95% CI -0.641 to -0.155, p=0.001) with favorable safety, but fibromyalgia patients were only a subset and heterogeneity was substantial, so this is indirect evidence for FM specifically.
學術資助 效應量：Hedges' g = -0.398 (95% CI -0.641 to -0.155), p=0.001
前往 PubMed
The Use of the Coenzyme Q10 as a Food Supplement in the Management of Fibromyalgia: A Critical Review
PMID: 36290691 2022 Narrative review
結論：This critical review concludes there is no sound scientific basis to regard CoQ10 as a gold-standard FM supplement: the supporting trials are small pilot studies, and prospective randomized trials with hundreds of patients per group are still required to confirm efficacy.
前往 PubMed

L4a US FDA
謹慎
not generally recognized as safe and effective for the referenced uses and therefore are considered "new drugs" 來源↗
L4b EU EFSA
反對
a cause and effect relationship has not been established between the consumption of coenzyme Q10 and the claimed effects 來源↗
L4c UK NHS
謹慎
Advise people with migraine that the food supplement riboflavin (400 mg once a day) may be effective in reducing migraine frequency and intensity for some people. 來源↗
L4d TW TFDA / 衛福部
謹慎
訂定「食品原料輔酵素Q10 (Coenzyme Q10)之使用限制及標示規定」 來源↗
L4e WHO
未表態
— 本適應症無對應資料

L5a NIH Office of Dietary Supplements
謹慎
— 本適應症無對應資料
L5b Mayo Clinic
中性
CoQ10 supplements might be beneficial for treating conditions such as congestive heart failure and preventing migraines. Most healthcare professionals think CoQ10 is safe, with few side effects... Some research suggests that CoQ10 might help ease the muscle weakness and pain that can happen when taking statins, though there isn't enough evidence to know for sure. 來源↗
L5c Cleveland Clinic
中性
— 本適應症無對應資料
L5d Harvard Health
中性
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
中性
Three drugs are FDA-approved for fibromyalgia: duloxetine (Cymbalta) and milnacipran (Savella) adjust brain chemicals to ease widespread pain. Pregabalin (Lyrica) blocks overactive nerve cells... Exercise is the most effective treatment: yoga, tai chi, or other low-impact aerobic activity. Acupuncture, chiropractic and massage can help. 來源↗

PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽

台灣社群關於輔酶 Q10「專門針對纖維肌痛症」的討論非常稀少，多數心得集中在提神、抗疲勞、心血管保健、備孕、與他汀類藥物併用緩解肌肉痠痛等用途；少數慢性疼痛/疲勞患者分享吃 Q10 後體力與睡眠改善，但鮮少特別點名纖維肌痛症。

💬社群實感

資料不足

破解迷思 社群最常見的 5 個誤解
✓
事實以為還原型 Q10 一定比氧化型有效，忽略個人吸收差異
✓
事實認為日本 DHC Q10 劑量比台灣版高就一定比較好（其實是法規差異）
✓
事實以為 Q10 可以取代醫師處方藥治療纖維肌痛或慢性疼痛
✓
事實誤以為 Q10 是即時止痛劑，幾天無感就停用
✓
事實忽略 Q10 應與油脂同服，空腹吞膠囊吸收差
🩹 社群通報的副作用
  • 晚上服用導致失眠或睡不好
  • 腸胃不適、輕微噁心
  • 與抗凝血劑（warfarin）併用造成凝血指標異常的疑慮
  • 少數人反映吃完反而疲倦
🏷️ 社群熱議品牌

依論壇被提及頻率，非銷售或品質排序。

  • Kaneka（還原型 Ubiquinol 原料）
  • DHC 輔酶 Q10
  • Doctor's Best 高吸收 CoQ10
  • 萊萃美 Nature Made Q10
  • 大研生醫 納豆紅麴 Q10
  • 21st Century Q10

⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

保健食品食用純化的Q10限制為每日30毫克

代表來源 ↗
L10b · TFDA 法定身份 官方認定

每日食用限量為三十毫克

來源 ↗

  • 運動治療
  • 認知行為治療
  • 核可藥物（度洛西汀、普瑞巴林）
✓ PMID 可查證引用皆附 NCBI PubMed 原始連結
🔬 7 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-09 claim_version: v11 engine_version: v1.0 claim_id: CLM-COND-fibromyalgia-INT-coenzyme-q10-001
查看 ClaimReview 結構化資料 (JSON-LD) 
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-fibromyalgia-INT-coenzyme-q10-001/",
  "datePublished": "2026-06-09",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "輔酶 Q10 (輔酵素 Q10)能改善纖維肌痛症",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}